Litigation Release No. 25024 / February 5, 2021
Securities and Exchange Commission v. Mark Ahn, No. 1:21-cv-10203 (D. Mass. filed February 5, 2021)
On February 5, 2021, the Securities and Exchange Commission charged Oregon resident Mark Ahn with insider trading in the securities of Massachusetts-based pharmaceutical company Dimension Therapeutics, Inc. in advance of an August 2017 merger announcement.
The SEC s complaint, filed in federal district court in Massachusetts, charges Ahn with violating the antifraud provisions of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder. The SEC seeks penalties, injunctive relief, and an order barring Ahn from serving as an officer or director of any SEC-reporting company.
Fraudster embroiled innocent relative in thoroughly dishonest insurance con
A judge said Sofia Hussain was thoroughly dishonest
Sofia Hussain leaves Birmingham Crown Court
Never miss another story from Coventry and Warwickshire by subscribing to our free email updatesInvalid EmailSomething went wrong, please try again later.
Subscribe
When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. OurPrivacy Noticeexplains more about how we use your data, and your rights. You can unsubscribe at any time.
Thank you for subscribingWe have more newslettersShow meSee ourprivacy notice